| Grant number: | 14/13334-7 |
| Support Opportunities: | Regular Research Grants |
| Start date: | March 01, 2016 |
| End date: | February 28, 2018 |
| Field of knowledge: | Health Sciences - Nutrition - Malnutrition and Physiological Development |
| Principal Investigator: | Maria Cristina Cintra Gomes Marcondes |
| Grantee: | Maria Cristina Cintra Gomes Marcondes |
| Host Institution: | Instituto de Biologia (IB). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil |
| City of the host institution: | Campinas |
| Associated researchers: | Bread Leandro Gomes da Cruz ; Emilianne Miguel Salomão |
Abstract
In our laboratory, we have as main objective the elucidation of metabolic and molecular effects of the cachectic state induced by tumour growth. Cancer-cachexia is considered a major problem in the treatment of solid tumours, especially pancreatic, stomach, lung and colon cancer, since these patients have intensive mobilization of host tissues, preferably depleting the skeletal muscle protein due to increased degradation and / or decreased protein synthesis in muscle. In contrast, pregnancy is characterized by maternal physiological changes, primarily correlated to hormones profile, especially oestrogen, progesterone, prolactin and hCG, essential to support foetal growth. Literature data report that the pregnancy hormones have influenced and modulated the risk and growth of breast cancer. Therefore, this proposal aims to investigate the effects of tumour growth, Walker-256 carcinoma and MAC16 colon adenocarcinoma, experimental models of cachexia, on the host spoliation and especially the mechanisms involved on protein catabolism and inhibition of muscle protein synthesis. Currently, we have a major interest to elucidate the mechanism of tissue catabolism induced by proteolysis-inducing (PIF) or Factor Walker (FW) factor, investigating the action mechanism of second messenger activated by PIF and FW in vitro in skeletal muscle cells (C2C12), fibroblast cells (Vero cells) and also trophoblastic cells (BeWo cells), and in vivo assays, assessing the activation of proteasome system and increased protein degradation, as well as the processes of protein synthesis inhibition in these processes associated with nutritional supplementation with leucine. This branched-chain amino acid acts as the structural element for the processes of protein synthesis and also is used as an energy source by skeletal muscle, and also leads the cell signalling process, preserving body protein mass. Thus, the main objective of this work is to evaluate how nutritional supplementation with leucine associated with the influence of pregnancy hormones can influence and modulate mainly the effects of Walker 256 tumour growth of in vitro and in vivo. Female Wistar rats will be distributed in eight different groups, such as: control (C), Walker-256 tumour-bearing (W), pregnant (P) and pregnant, tumour bearing (PW); and four groups fed with a leucine-rich diet: control leucine (L), tumour-bearing leucine (LW), pregnant fed leucine-rich diet (LP); pregnant tumour-bearing fed leucine-rich diet (LPW). After 19 days of experiment, the animals will be sacrificed for analysis of metabolomic profile, concentrations of hormones and cytokines in serum and the muscle, placenta, foetal and tumour tissues metabolomic and proteomics profiles, protein expression related to synthesis and degradation processes will be analysed and also the cell signalling, proliferation and apoptosis. In in vitro experiments, the Walker-256 tumour cells established in culture will be treated with pregnancy hormones and evaluate the proliferation and cytotoxicity on these cells and also the effects on cell signalling proteins and apoptosis. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |